Nice & Green

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients. Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small-molecule drugs and other compounds. In particular, their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches. The company is headquartered in Reinach, Switzerland.

MelodyVR is a Virtual Reality music platform available in the US, UK and Europe. MelodyVR is the only licensed VR music platform in the world and has secured partnerships with all the major record labels - Universal Music Group, Sony Music Entertainment Warner Music Group as well as Jay Z’s Roc Nation and many more. The companies end-to-end process has helped some of the world’s biggest artists take their first steps into virtual reality. They boast the world's largest library of interactive music content, having worked with over 650 international artists to date. Users can have multiple perspectives- from deep in the crowd to up-close-and-personal with the band on stage. As well as recorded shows, the company will live stream concerts via Virtual Reality having partnered with a number of major UK venues.

Rapid Nutrition is a producer of natural nutrition products. They provide services that include research, development, and production of evidence-based nutrition. An online inquiry form is available on the company's website.

Evolva is a biotech company that develops and commercializes ready-to-formulate and nature-based ingredients. Evolva was founded in 2004 around a distinctive, proprietary, technology platform that uses synthetic biology to create innovative small-molecule drugs and other compounds. In particular, their platform allows the creation of chemistries that recapitulate the themes found in natural products, but without the disadvantages of those approaches. The company is headquartered in Reinach, Switzerland.

Bublar Group brings the magic digital world into your reality. We now develop the next generation of mobile gaming by combining smartphone technology with augmented- and virtual reality. We enable smartphone users to create personal real-time moving 3D-objects seamlessly deployed in the real world in a fun and engaging way. Our team is based in Stockholm, Sweden, with deep experience in real-time 3D graphics, simulation systems, eye-tracking, location based services and VR/AR combined with mobile games and applications.

Artificial Solutions® (SSME:ASAI) is the leading specialist in Conversational AI. We enable communication with applications, websites and devices in everyday, humanlike natural language via voice, text, touch or gesture input. Artificial Solutions’ advanced conversational AI Teneo®, allows business users and developers to create sophisticated, highly intelligent applications that run across 86 languages and dialects, multiple platforms and channels in record time. The ability to analyse and make use of the enormous quantities of conversational data is fully integrated within Teneo, delivering unprecedented levels of data insight that reveal what customers are truly thinking.Artificial Solutions’ conversational AI technology makes it easy to implement a wide range of natural language applications such as virtual assistants, conversational bots, speech-based conversational UIs for smart devices and more. It is already used daily by millions of people across hundreds of private and public sector deployments worldwide. For more information, please visit www.artificial-solutions.com

Itway S.p.A is a company that operates in the IT sector through the planning, production and distribution of technologies and solutions in the cyber security sector.

WISeKey is a global cybersecurity company that specializes in digital identity management and secure authentication. Based in Switzerland, the company deploys large-scale digital identity ecosystems using its patented cryptographic Root of Trust (RoT), which ensures secure identification in both physical and virtual environments, catering to the Internet of Things, Blockchain, and Artificial Intelligence sectors. WISeKey's integrated Vertical Trusted Platform combines hardware and software solutions, including proprietary technologies like RoT and Public Key Infrastructure (PKI), to help clients manage their digital identities and communications seamlessly. As the proliferation of internet-based devices increases, WISeKey addresses the associated cybersecurity challenges by providing comprehensive solutions that protect digital footprints and adapt to evolving security needs. The company’s offerings include managed PKI services and specialized semiconductor chips, which form the core of its cybersecurity Software as a Service (SaaS) business model.

FacePhi is the leading Spanish company in biometric solutions for identity verification, specialized in facial recognition systems, digital onboarding and safe work environments. Based in Alicante and operating worldwide, the company has a presence in more than 25 countries, has performed more than 1 trillion authentications, 21 million access programs and has a strong presence in the banking sector. The drive of biometrics to improve customer experience and protect data from citizens and entities is the hallmark of the firm.

Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumors and varicose veins. Their companyTheraclion a French company created in 2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures, and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limbs.

Saniona is a pharmaceutical company focusing on the development and advancement of multiple potential new medicines through clinical trials. The company is pioneering in the development of highly selective ion channel modulators. Ion channel modulation is a well-established approach to disease treatment that has been used in medications for diabetes, hypertension, epilepsy, and other conditions. TesometTM, the company's most advanced product candidate, has advanced to mid-stage clinical trials for rare eating disorders. Saniona is advancing two product candidates, SAN711 and SAN903, using its ion channel expertise. A Phase 1 clinical trial of SAN711 for the treatment of neuropathic pain conditions was completed successfully. SAN903 is now ready for Phase 1 clinical trials to treat inflammatory and fibrotic disorders.